PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
51.07%
Revenue growth above 1.5x CX's 13.14%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
126.19%
Gross profit growth above 1.5x CX's 22.43%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
81150.00%
EBIT growth above 1.5x CX's 38.52%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
81150.00%
Operating income growth above 1.5x CX's 38.52%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
4382.14%
Net income growth above 1.5x CX's 20.58%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
3260.00%
EPS growth above 1.5x CX's 20.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
3240.00%
Diluted EPS growth above 1.5x CX's 20.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.55%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
0.07%
Slight or no buyback while CX is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
348.73%
OCF growth under 50% of CX's 2725.78%. Michael Burry might suspect questionable revenue recognition or rising costs.
222.63%
FCF growth 1.25-1.5x CX's 183.13%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
19.40%
10Y revenue/share CAGR 1.25-1.5x CX's 15.00%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
-7.17%
Negative 5Y CAGR while CX stands at 25.19%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
67.54%
3Y revenue/share CAGR similar to CX's 73.01%. Walter Schloss would assume both companies experience comparable short-term cycles.
454.70%
10Y OCF/share CAGR in line with CX's 504.28%. Walter Schloss would see both as similarly efficient over the decade.
709.47%
Positive OCF/share growth while CX is negative. John Neff might see a comparative advantage in operational cash viability.
74.50%
3Y OCF/share CAGR under 50% of CX's 162.90%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
2171.35%
Net income/share CAGR above 1.5x CX's 290.58% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
262.25%
Positive 5Y CAGR while CX is negative. John Neff might view this as a strong mid-term relative advantage.
527.11%
3Y net income/share CAGR 50-75% of CX's 784.08%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
100.66%
10Y equity/share CAGR above 1.5x CX's 6.20%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
52.71%
5Y equity/share CAGR above 1.5x CX's 30.37%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
19.29%
Below 50% of CX's 51.91%. Michael Burry suspects a serious short-term disadvantage in building book value.
165.77%
Dividend/share CAGR of 165.77% while CX is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
143.14%
Dividend/share CAGR of 143.14% while CX is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
50.42%
3Y dividend/share CAGR of 50.42% while CX is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.55%
Under 50% of CX's 5.74%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
120.90%
SG&A growth well above CX's 9.12%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.